Catch up on the top radiology content of the past week.
|Articles|November 20, 1996
Sectra to install PACS in Norway
PACS developer Sectra-Imtec has won a contract to install itsPACS technology at Central Hospital of Vestfold in Tonsberg, Norway.Sectra, of Linköping, Sweden, said the hospital intends todigitize all modalities in its radiology department, and
Advertisement
PACS developer Sectra-Imtec has won a contract to install itsPACS technology at Central Hospital of Vestfold in Tonsberg, Norway.Sectra, of Linköping, Sweden, said the hospital intends todigitize all modalities in its radiology department, and willuse data encryption technology developed by Sectra to ensure patientprivacy. Sectra's PACS products are sold in the U.S. by PhilipsMedical Systems (SCAN 10/9/96).
Advertisement
Related to this article
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Emerging Research Insights and New Advances in Neuroradiology
2
Diagnostic Imaging's Weekly Scan: September 27 — October 3
3
MRI, CT or Ultrasound: Which Modality Offers the Most Utility for Imaging of Pancreatic Cancer?
4
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
5